Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the "copycat" drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes ...
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...
With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies ...
On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 ...